Mural Oncology plc – NASDAQ:MURA

Mural Oncology stock price today

$1.85
-1.37
-42.55%
Financial Health
0
1
2
3
4
5
6
7
8
9

Mural Oncology stock price monthly change

-1.53%
month

Mural Oncology stock price quarterly change

-1.53%
quarter

Mural Oncology stock price yearly change

-41.98%
year

Mural Oncology key metrics

Market Cap
55.44M
Enterprise value
N/A
P/E
N/A
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
N/A
Price/Book
N/A
PEG ratio
N/A
EPS
-11.61
Revenue
N/A
EBITDA
-185.37M
Income
-194.04M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Mural Oncology stock price history

Mural Oncology stock forecast

Mural Oncology financial statements

Mural Oncology plc (NASDAQ:MURA): Profit margin
Jun 2023 0 -52.30M
Sep 2023 0 -51.27M
Dec 2023 0 -59.53M
Mar 2024 0 -30.91M
Mural Oncology plc (NASDAQ:MURA): Analyst Estimates
Dec 2023 0 -59.53M
Mar 2024 0 -30.91M
Sep 2025 0 -28.21M
Dec 2025 0 -28.54M
  • Analysts Price target

  • Financials & Ratios estimates

Mural Oncology plc (NASDAQ:MURA): Earnings per share (EPS)
2024-05-14 -2.66 -1.84
2024-08-13 -1.9 -1.86
Mural Oncology plc (NASDAQ:MURA): Debt to assets
Jun 2023 300983000 16.45M 5.47%
Sep 2023 30202000 37.09M 122.82%
Dec 2023 301745000 37.92M 12.57%
Mar 2024 263504000 28.57M 10.84%
Mural Oncology plc (NASDAQ:MURA): Cash Flow
Jun 2023 -45.31M -710K 46.02M
Sep 2023 -50.47M -1.16M 51.63M
Dec 2023 -42.72M -1.17M 315.01M
Mar 2024 -37.33M -124.54M 0

Mural Oncology alternative data

Mural Oncology plc (NASDAQ:MURA): Employee count
Feb 2024 110
Mar 2024 117
Apr 2024 117
May 2024 117
Jun 2024 119
Jul 2024 119

Mural Oncology other data

Mural Oncology plc (NASDAQ:MURA): Insider trades (number of shares)
Period Buy Sel
Jul 2024 0 14688
Aug 2024 10000 0
Oct 2024 0 7421
Nov 2024 0 5069
Dec 2024 0 5318
Transaction Date Insider Security Shares Price per share Total value Source
Sale
KESON-BROOKES MAIKEN officer: See Remarks
Ordinary Shares 2,555 $3.27 $8,355
Sale
LOEW CAROLINE director, officer: Chief Execut..
Ordinary Shares 2,763 $3.4 $9,394
Sale
GOODMAN VICKI L officer: Chief Medical Officer
Ordinary Shares 5,069 $3.33 $16,880
Sale
CUTLER ADAM D. officer: Chief Financial Officer
Ordinary Shares 7,421 $3.41 $25,306
Purchase
ALTSCHULLER SUSAN director Ordinary Shares 10,000 $3.21 $32,070
Sale
KESON-BROOKES MAIKEN officer: See Remarks
Ordinary Shares 2,157 $3.41 $7,355
Sale
LOEW CAROLINE director, officer: Chief Execut..
Ordinary Shares 12,531 $2.91 $36,465
Tuesday, 3 December 2024
globenewswire.com
Wednesday, 20 November 2024
globenewswire.com
Monday, 11 November 2024
globenewswire.com
Thursday, 7 November 2024
globenewswire.com
Monday, 4 November 2024
globenewswire.com
Monday, 7 October 2024
globenewswire.com
Wednesday, 2 October 2024
globenewswire.com
Monday, 23 September 2024
globenewswire.com
Tuesday, 10 September 2024
globenewswire.com
Wednesday, 4 September 2024
globenewswire.com
Tuesday, 27 August 2024
globenewswire.com
Tuesday, 13 August 2024
globenewswire.com
Friday, 2 August 2024
globenewswire.com
Wednesday, 31 July 2024
globenewswire.com
Tuesday, 2 July 2024
globenewswire.com
Wednesday, 5 June 2024
globenewswire.com
Tuesday, 4 June 2024
globenewswire.com
Tuesday, 14 May 2024
globenewswire.com
  • What's the price of Mural Oncology stock today?

    One share of Mural Oncology stock can currently be purchased for approximately $1.85.

  • When is Mural Oncology's next earnings date?

    Unfortunately, Mural Oncology's (MURA) next earnings date is currently unknown.

  • Does Mural Oncology pay dividends?

    No, Mural Oncology does not pay dividends.

  • How much money does Mural Oncology make?

    Mural Oncology has a market capitalization of 55.44M. Mural Oncology made a loss 207.45M US dollars in net income (profit) last year or -$1.86 on an earnings per share basis.

  • What is Mural Oncology's stock symbol?

    Mural Oncology plc is traded on the NASDAQ under the ticker symbol "MURA".

  • What is Mural Oncology's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Mural Oncology?

    Shares of Mural Oncology can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Mural Oncology have?

    As Jul 2024, Mural Oncology employs 119 workers, which is 2% more then previous quarter.

  • When Mural Oncology went public?

    Mural Oncology plc is publicly traded company for just a year since IPO on 16 Nov 2023.

  • What is Mural Oncology's official website?

    The official website for Mural Oncology is muraloncology.com.

  • How can i contact Mural Oncology?

    Mural Oncology can be reached via phone at +353 1 905 8020.

Mural Oncology company profile:

Mural Oncology plc

muraloncology.com
Exchange:

NASDAQ

Full time employees:

107

Industry:

Biotechnology

Sector:

Healthcare

Mural Oncology Plc, a clinical-stage oncology company, focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company's lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherapy and platinum-resistant ovarian cancer in combination with pembrolizumab. It also develops engineered interleukin-18 and tumor-targeted interleukin-12 programs. The company was incorporated in 2017 and is based in Dublin, Ireland. As of November 15, 2023, Mural Oncology Plc operates as a former subsidiary of Alkermes plc.

10 Earlsfort Terrace
Dublin, D02 T380

CIK: 0001971543
ISIN: IE000LK2BOB4
: